INTERLEUKIN GENETICS INC: 10-Q filed 2015-08-14
What INTERLEUKIN GENETICS INC reported in its quarterly report filed 2015-08-14 (fiscal Q2 2015): 32 published measures, 96 facts as tagged in accession 0001144204-15-049138.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-08-14
- Fiscal period
- fiscal Q2 2015
- Accession
- 0001144204-15-049138 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INTERLEUKIN GENETICS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 9,428,763 | USD | |
| At 2014-12-31 | 13,267,121 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 8,510,021 | USD | |
| At 2014-12-31 | 8,750,264 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 918,742 | USD | |
| At 2014-12-31 | 4,516,857 | USD | |
| At 2014-06-30 | 2,276,099 | USD | |
| At 2013-12-31 | 5,253,222 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 7,691,919 | USD | |
| At 2014-12-31 | 11,466,807 | USD | |
| At 2014-06-30 | 4,191,356 | USD | |
| At 2013-12-31 | 7,542,281 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -2,166,786 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -4,009,981 | USD | 181 |
| 2014-01-01 to 2014-12-31 | 6,300,000 | USD | 365 |
| 2014-04-01 to 2014-06-30 | -1,576,647 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -3,241,166 | USD | 181 |
| 2013-01-01 to 2013-12-31 | 7,100,000 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 21,518 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 61,250 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 376,051 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 779,263 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 528,595 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 1,016,161 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | -125,100,293 | USD | |
| At 2014-12-31 | -121,090,312 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 0 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 0 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 0 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 0 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 691,934 | USD | |
| At 2014-12-31 | 773,779 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 252,925 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 399,235 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 122,578 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 244,799 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -2,014,682 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -3,707,246 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -1,578,252 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -3,244,765 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 8,474,829 | USD | |
| At 2014-12-31 | 12,180,658 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 152,104 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 302,957 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 0 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 0 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 3,736,555 | USD | |
| At 2014-12-31 | 4,011,650 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 360,238 | USD | |
| At 2014-12-31 | 513,927 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 7,623 | USD | |
| At 2014-12-31 | 14,013 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 2,059,178 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 3,823,913 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,745,101 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 3,504,409 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 159,048 | USD | |
| At 2014-12-31 | 171,575 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 44,496 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 116,667 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 166,849 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 259,644 | USD | 181 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 331,555 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 662,596 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 361,746 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 756,517 | USD | 181 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 1,655,226 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 3,218,017 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,506,057 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 3,032,663 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 384,538 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 567,068 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 215,519 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 424,696 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 172,786,907 | shares | |
| At 2014-12-31 | 172,683,342 | shares |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 156,937 | USD | |
| At 2014-12-31 | 195,765 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 105,063 | USD | |
| At 2014-12-31 | 116,919 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 407,498 | USD | |
| At 2014-12-31 | 343,225 | USD |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 19,414 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 38,828 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 23,525 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 47,050 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -152,104 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -302,735 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,605 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 3,599 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | -6,390 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 11,725 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | -12,527 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 108 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | -153,689 | USD | 181 |
| 2014-01-01 to 2014-06-30 | -433,965 | USD | 181 |
Inspect the source
- Entity
- INTERLEUKIN GENETICS INC / CIK 0001037649
- Captured
- SEC response SHA-256
a1dec64965ae0507fde1f8bdab94feeb924a2817b4582e8fe10de362809c5bbd
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001037649.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))